Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors.

about

Targeting tumour microenvironment by tyrosine kinase inhibitor.Mechanisms of Resistance to PD-1 and PD-L1 Blockade.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression

P2860

Q49887906-94CAA419-B4E9-4ACA-8C71-1A05BAA8B840 Q52707883-FF0D9D7C-B1C7-491F-97C6-8EFE3B1B5D16 Q57817490-F15E897B-12F8-47AF-88E9-72F70908FC89 Q58780996-50DEB0E0-9F47-4021-ADFB-29BAC54BA48D

P2860

Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors.

Item

http://www.wikidata.org/entity/Q38716324

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Myeloid Cells That Impair Immu ...... Resistance to BRAF Inhibitors.

@en

type

Item

label

Myeloid Cells That Impair Immu ...... Resistance to BRAF Inhibitors.

@en

prefLabel

Myeloid Cells That Impair Immu ...... Resistance to BRAF Inhibitors.

@en

P1476

Myeloid Cells That Impair Immu ...... Resistance to BRAF Inhibitors.

@en

P2093

Aleksey Molodtsov

http://www.w3.org/2001/XMLSchema#string

Andrea Boni

http://www.w3.org/2001/XMLSchema#string

Brian T Malik

http://www.w3.org/2001/XMLSchema#string

Christina V Angeles

http://www.w3.org/2001/XMLSchema#string

Mary Jo Turk

http://www.w3.org/2001/XMLSchema#string

Michael L Whitfield

http://www.w3.org/2001/XMLSchema#string

Peisheng Zhang

http://www.w3.org/2001/XMLSchema#string

Shannon M Steinberg

http://www.w3.org/2001/XMLSchema#string

Tamara A Wood

http://www.w3.org/2001/XMLSchema#string

Tamer B Shabaneh

http://www.w3.org/2001/XMLSchema#string

P2860

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib

Significance analysis of microarrays applied to the ionizing radiation response

Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Mechanisms of resistance to RAF inhibition in melanomas harboring a BRAF mutation

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

Hepatotoxicity with combination of vemurafenib and ipilimumab

Java Treeview--extensible visualization of microarray data

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.

P304

1599-1610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-16-1755

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28202513

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5380540

http://www.w3.org/2001/XMLSchema#string

Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors.

about

P2860

P2860

Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932